Bausch Health Companies (BHC) Other financing activities (2009 - 2026)

Bausch Health Companies has reported Other financing activities for 18 years, with the latest figure at -$7.0 million in Q2 2026.

• Quarterly Other financing activities rose 12.5% year-over-year to -$7.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$11.0 million (up 42.11% YoY) and the FY2025 annual result came in at -$10.0 million, up 9.09% from the prior year.
• Other financing activities slipped to -$7.0 million in Q2 2026 per BHC's latest filing, from -$2.0 million in the prior quarter.
• Over five years, Other financing activities peaked at $1.0 million in Q1 2022 and troughed at -$12.0 million in Q3 2022.
• A 5-year average of -$3.5 million and a median of -$2.0 million in 2024 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2025: Other financing activities plunged 200.0% in 2022, then surged 88.89% in 2025.
• Over 5 years, Other financing activities stood at -$1.0 million in 2022, then slumped by 200.0% to -$3.0 million in 2023, then jumped by 33.33% to -$2.0 million in 2024, then jumped by 50.0% to -$1.0 million in 2025, then plunged by 600.0% to -$7.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$7.0 million, -$2.0 million, and -$1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.